7,554
Participants
Start Date
June 30, 2003
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
clopidogrel (SR25990C)
oral administration (tablets)
placebo
oral administration (tablets)
Sanofi-Aventis Administrative Office, Bridgewater
Sanofi-Aventis Administrative Office, Buenos Aires
Sanofi-Aventis Administrative Office, Macquarie Park
Sanofi-Aventis, Vienna
Sanofi-aventis Administrative Office, Diegem
Sanofi-Aventis Administrative Office, São Paulo
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Santiago
Sanofi-Aventis Administrative Office, Prague
Sanofi-Aventis Administrative Office, Hørsholm
Sanofi-Aventis Administrative Office, Helsinki
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Berlin
Sanofi-Aventis Administrative Office, Athens
Sanofi-Aventis Administrative Office, Causeway Bay
Sanofi-Aventis Administrative Office, Budapest
Sanofi-Aventis Administrative Office, Milan
Sanofi-Aventis Administrative Office, Kuala Lumpur
Sanofi-Aventis Administrative Office, México
Sanofi-Aventis Administrative Office, Gouda
Sanofi-Aventis Administrative Office, Lysaker
Sanofi-Aventis Administrative Office, Warsaw
Sanofi-Aventis Administrative Office, Porto Salvo
Sanofi-Aventis Administrative Office, Singapore
Sanofi-Aventis Administrative Office, Midrand
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Bromma
Sanofi-Aventis Administrative Office, Geneva
Sanofi-Aventis Administrative Office, Taipei
Sanofi-Aventis Administrative Office, Guildford Surrey
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Sanofi
INDUSTRY